Highly Leveraged Drug Manufacturers - Specialty & Generic Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1LNTH Lantheus Holdings
619.44 M
(0.06)
 4.34 
(0.25)
2RMTI Rockwell Medical
13.54 M
 0.06 
 5.99 
 0.33 
3CXBS Corix Bioscience
5.08 M
 0.00 
 0.00 
 0.00 
4PXYN Praxsyn Corp
3.68 M
 0.13 
 125.00 
 15.63 
5EWPI Emerging World Pharma
3.2 M
 0.00 
 0.00 
 0.00 
6WPHM Winston Pharmaceuticals
1.19 M
 0.00 
 0.00 
 0.00 
7ORGH OrgHarvest
1.1 M
 0.00 
 0.00 
 0.00 
8SXTC China SXT Pharmaceuticals
983.88 K
 0.00 
 5.71 
(0.01)
9NSRS North Springs Resources
945.29 K
 0.00 
 0.00 
 0.00 
10SKTO Sk3 Group
603.37 K
 0.00 
 0.00 
 0.00 
11APUS Apimeds Pharmaceuticals US,
596.84 K
 0.10 
 6.22 
 0.61 
12KALY Kali Inc
401.3 K
 0.00 
 0.00 
 0.00 
13KGET Kleangas Energy Tech
222.55 K
 0.00 
 0.00 
 0.00 
14LSDIF Lucy Scientific Discovery
60.42 K
 0.12 
 125.50 
 14.66 
15RNBI Rainbow International Corp
33.97 K
 0.00 
 0.00 
 0.00 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.